Font Size: a A A
Keyword [Proliferator activated receptor]
Result: 41 - 60 | Page: 3 of 10
41. Experimental Study Of Mechanism Of Diabetic Cardiomyopathy And Cardiac Protective Effect From Energy Metabolism Intervention
42. Effects And Mechanisms Of Peroxisome Proliferator-activated Receptor-γ (PPAR-γ) Ligands On Inflammatory Response Induced By Oxidative Stress In Rat Cardiac Myocytes
43. Design, Synthesis And SAR Of Novel Peroxisome Proliferator-activated Receptor Agonists
44. Role Of Poly (ADP-ribose) Polymerase 1 In The Regulation Of Gene Transcription In Cardiovascular System
45. Gene Silencing Targeted On Peroxisome Proliferator-activated Receptor γ Affect Biological Behaviour Of Hepatoma
46. The Effects And Mechanisms Of Simvastatin On Ventricular Remodeling And Heart Function In Chronic Heart Failure Rabbit Models
47. The Protective Effect And Mechanism Of Rhein On Renal In Obese Diabetic Rats
48. Effects Of Telmisartan Ameliorating Chronic Pancreatitis In Rats And The Study Of Its Mechanism
49. Inhibiting Effect Of Rosiglitazone And Rapamycin Combination On Cystic Epithelial Cells In ADPKD And Its Mechanism
50. Inhibitory Effect On Corneal Allograft Rejection By Peroxisome Proliferator-Activated Receptor Gamma Agonist
51. The Influence Of LPS-induced Expression Of COX-2 And PPAR-γ On The Differentiation Of Orbital Preadipocytes In Thyroid-associated Ophthalmopathy
52. Research Of Protective Effects And Mechanisms Of Polydatin On Nonalcoholic Fatty Liver Disease
53. Effect Of Telmisartan On Glucose Homeostasis Of Skeletal Muscle And Its Mechanism
54. Beneficial Effects Of THSG On Acetic Acid-induced Experimental Colitis: Involvement Of Upregulating PPAR-γ And Inhibiting NF-κB Inflammatory Pathway
55. Mitochondrial Dysfunction Mediates Podocyte Damage And Targeted Therapy
56. The Effect And Related Mechanism Of The Downregulation Of Peroxisome Proliferator-activated Receptor-γ On Advanced Glycation End Products-induced Expression Of Tumor Necrosis Factor-α And Matrix Metalloproteinase-13 In Rabbit Chondrocytes
57. The Of P38mapk Mechanism In Diabetic Nephropathy Study
58. Experimental Study Of The Peroxisome Proliferator-activated Receptor ¦Ã Agonist Treatment Of Pituitary Adenomas
59. Phosphoinositide 3-kinase Regulatory Subunit, The Peroxisome Proliferator - Activated Receptor Gamma Coactivator Agent-1¦Á And Calpain-10 Gene Genetic Variation And Type 2 Diabetes And Hypertension Association Studies
60. Peroxisome Proliferator-activated Receptor ¦Ã In Airway Inflammation In Asthma And Reconstruction
  <<First  <Prev  Next>  Last>>  Jump to